WHO COVID-19 Trial drops hydroxychloroquine, HIV combo lopinavir/ritonavir after ‘lack of evidence’ in hospitalised patients

The World Health Organisation has pulled the steroid drug hydroxychloroquine and HIV treatment combination lopinavir/ritonavir from their ongoing COVID-19 Solidarity trials, after a recommendation from the international Steering Committee advising the same. The Solidarity Trial, established by WHO, is working to find a working treatment in hospitalized patients.

The Committee’s recommendation comes after mounting evidence comparing hydroxychloroquine and lopinavir/ritonavir with standard-of-care treatment from the Trial’s interim results,

Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19 

The jury is still out on Hydroxychloroquine after the global debacle have left scientists uncertain of its usage

Read the Rest at FIRSTPOST

Leave a Reply

Your email address will not be published. Required fields are marked *